Trial Profile
A Phase II Trial of Postoperative Proton Radiotherapy With Concomitant Chemotherapy for Patients With Resected Pancreatic Adenocarcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- Acronyms PC03
- 01 Sep 2017 Status changed from active, no longer recruiting to completed.
- 17 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 08 May 2013 Planned End Date changed from 1 Feb 2020 to 1 Feb 2022 as reported by ClinicalTrials.gov.